$1.00
-0.04-3.85%
At Close: -
$1.01
0.011.00%
After Hours: Jul 3, 3:09 PM EDT
15 minutes delayed
ImmunoPrecise Antibodies
IPANASDAQ
ImmunoPrecise Antibodies (NASDAQ:IPA) Stock, Analyst Ratings, Price Targets, Predictions
ImmunoPrecise Antibodies Ltd has a consensus price target of $7, established from looking at the 9 latest analyst ratings. The last 3 analyst ratings were released from Benchmark, HC Wainwright & Co., and HC Wainwright & Co. on March 15, 2024, March 15, 2024, and September 18, 2023. With an average price target of $7.67 between Benchmark, HC Wainwright & Co., and HC Wainwright & Co., there's an implied 659.08% upside for ImmunoPrecise Antibodies Ltd from these 3 analyst ratings.
Analyst Firms Making Recommendations1
Benchmark
HC Wainwright & Co.
1calculated from analyst ratings
Analyst Ratings for ImmunoPrecise Antibodies
| Buy Now | Get Alert | |||||||
|---|---|---|---|---|---|---|---|---|
| 03/15/2024 | Buy Now | 395.05% | Benchmark | Robert Wasserman | → $5 | Reiterates | Speculative Buy → Speculative Buy | Get Alert |
| 03/15/2024 | Buy Now | 791.09% | HC Wainwright & Co. | Swayampakula Ramakanth | → $9 | Reiterates | Buy → Buy | Get Alert |
| 09/18/2023 | Buy Now | 791.09% | HC Wainwright & Co. | Swayampakula Ramakanth | → $9 | Reiterates | Buy → Buy | Get Alert |
| 07/12/2023 | Buy Now | 791.09% | HC Wainwright & Co. | Swayampakula Ramakanth | → $9 | Reiterates | Buy → Buy | Get Alert |
| 07/11/2023 | Buy Now | 593.07% | Benchmark | Robert Wasserman | → $7 | Reiterates | Speculative Buy → Speculative Buy | Get Alert |
| 03/21/2023 | Buy Now | 593.07% | Benchmark | Robert Wasserman | $12 → $7 | Maintains | Speculative Buy | Get Alert |
| 03/17/2023 | Buy Now | 791.09% | HC Wainwright & Co. | Swayampakula Ramakanth | → $9 | Reiterates | → Buy | Get Alert |
| 12/02/2022 | Buy Now | 791.09% | HC Wainwright & Co. | Swayampakula Ramakanth | → $9 | Initiates | → Buy | Get Alert |
| 10/25/2021 | Buy Now | 1088.12% | Benchmark | Robert Wasserman | — | Initiates | → Buy | Get Alert |
FAQ
What is the target price for ImmunoPrecise Antibodies (IPA) stock?
The latest price target for ImmunoPrecise Antibodies (NASDAQ:IPA) was reported by Benchmark on March 15, 2024. The analyst firm set a price target for $5.00 expecting IPA to rise to within 12 months (a possible 395.05% upside). 5 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for ImmunoPrecise Antibodies (IPA)?
The latest analyst rating for ImmunoPrecise Antibodies (NASDAQ:IPA) was provided by Benchmark, and ImmunoPrecise Antibodies reiterated their speculative buy rating.
When was the last upgrade for ImmunoPrecise Antibodies (IPA)?
There is no last upgrade for ImmunoPrecise Antibodies
When was the last downgrade for ImmunoPrecise Antibodies (IPA)?
There is no last downgrade for ImmunoPrecise Antibodies.
When is the next analyst rating going to be posted or updated for ImmunoPrecise Antibodies (IPA)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of ImmunoPrecise Antibodies, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for ImmunoPrecise Antibodies was filed on March 15, 2024 so you should expect the next rating to be made available sometime around March 15, 2025.
Is the Analyst Rating ImmunoPrecise Antibodies (IPA) correct?
While ratings are subjective and will change, the latest ImmunoPrecise Antibodies (IPA) rating was a reiterated with a price target of $0.00 to $5.00. The current price ImmunoPrecise Antibodies (IPA) is trading at is $1.01, which is within the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.